Pediatric triglycerides predict cardiovascular disease events in the fourth to fifth decade of life

Metabolism: Clinical and Experimental

Volumn 58, Issue 9, 2009, Pages 1277-1284

  Morrison, John A ^a   Glueck, Charles J ^b   Horn, Paul S ^c,d   Yeramaneni, Samrat ^b   Wang, Ping ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b JEWISH HOSPITAL   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHILD; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LONGITUDINAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGING; CARDIOVASCULAR DISEASES; CHILD; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; POPULATION; PROGNOSIS; TRIGLYCERIDES;

EID: 68549087040     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.04.009     Document Type: Article

References (54)

1. Criqui M.H., Heiss G., Cohn R., et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 328 (1993) 1220-1225
2. Sarwar N., Danesh J., Eiriksdottir G., et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 115 (2007) 450-458
3. Bansal S., Buring J.E., Rifai N., et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298 (2007) 309-316
4. McBride P.E. Triglycerides and risk for coronary heart disease. JAMA 298 (2007) 336-338
5. Nordestgaard B.G., Benn M., Schnohr P., et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298 (2007) 299-308
6. Austin M.A., McKnight B., Edwards K.L., et al. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study. Circulation 101 (2000) 2777-2782
7. Espinola-Klein C., Rupprecht H.J., Bickel C., et al. Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis. Am J Cardiol 99 (2007) 1623-1628
8. Wittrup H.H., Tybjaerg-Hansen A., and Nordestgaard B.G. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 99 (1999) 2901-2907
9. Bonora E., Kiechl S., Willeit J., et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Diabetes Care 30 (2007) 318-324
10. Frick M.H., Elo O., Haapa K., et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317 (1987) 1237-1245
11. Rubins H.B., Robins S.J., Collins D., et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 341 (1999) 410-418
12. Rubins H.B., Robins S.J., Collins D., et al. Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Arch Intern Med 162 (2002) 2597-2604
13. Keech A., Simes R.J., Barter P., et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366 (2005) 1849-1861
14. Bloomfield Rubins H., Davenport J., Babikian V., et al. Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation 103 (2001) 2828-2833
15. Miller M., Cannon C.P., Murphy S.A., et al. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 51 (2008) 724-730
16. Berenson G.S., Srinivasan S.R., Bao W., et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338 (1998) 1650-1656
17. McGill Jr. H.C., McMahan C.A., and Gidding S.S. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation 117 (2008) 1216-1227
18. Freedman D.S., Patel D.A., Srinivasan S.R., et al. The contribution of childhood obesity to adult carotid intima-media thickness: the Bogalusa Heart Study. Int J Obes (Lond) 32 (2008) 749-756
19. Juonala M., Viikari J.S., Kahonen M., et al. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study. J Am Coll Cardiol 52 (2008) 293-299
20. Juonala M., Jarvisalo M.J., Maki-Torkko N., et al. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study. Circulation 112 (2005) 1486-1493
21. Juonala M., Viikari J.S., Ronnemaa T., et al. Associations of dyslipidemias from childhood to adulthood with carotid intima-media thickness, elasticity, and brachial flow-mediated dilatation in adulthood: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 28 (2008) 1012-1017
22. Sun S.S., Liang R., Huang T.T., et al. Childhood obesity predicts adult metabolic syndrome: the Fels Longitudinal Study. J Pediatr 152 (2008) 191-200
23. Davis P.H., Dawson J.D., Riley W.A., et al. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 104 (2001) 2815-2819
24. Friedman L.A., Morrison J.A., Daniels S.R., et al. Sensitivity and specificity of pediatric lipid determinations for adult lipid status: findings from the Princeton Lipid Research Clinics Prevalence Program Follow-up Study. Pediatrics 118 (2006) 165-172
25. Laskarzewski P., Morrison J.A., Mellies M.J., et al. Relationships of measurements of body mass to plasma lipoproteins in schoolchildren and adults. Am J Epidemiol 111 (1980) 395-406
26. Morrison J.A., deGroot I., Edwards B.K., et al. Plasma cholesterol and triglyceride levels in 6,775 school children, ages 6-17. Metabolism 26 (1977) 1199-1211
27. Williams O.D., Stinnett S., Chambless L.E., et al. Populations and methods for assessing dyslipoproteinemia and its correlates. The Lipid Research Clinics Program Prevalence Study. Circulation 73 (1986) I4-I11
28. Obesity and cardiovascular disease risk factors in black and white girls: the NHLBI Growth and Health Study. Am J Public Health 82 (1992) 1613-1620
29. Austin P.C. Using the bootstrap to improve estimation and confidence intervals for regression coefficients selected using backwards variable elimination. Stat Med 27 (2008) 3286-3300
30. Weber F. Risk factors for subclinical carotid atherosclerosis in healthy men. Neurology 59 (2002) 524-528
31. Crouse III J.R., Tang R., Espeland M.A., et al. Associations of extracranial carotid atherosclerosis progression with coronary status and risk factors in patients with and without coronary artery disease. Circulation 106 (2002) 2061-2066
32. Price J.F., Mowbray P.I., Lee A.J., et al. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J 20 (1999) 344-353
33. Ness J., Aronow W.S., and Ahn C. Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice. J Am Geriatr Soc 48 (2000) 312-314
34. Genoud M., Wietlisbach V., Feihl F., et al. Surrogate markers for atherosclerosis in overweight subjects with atherogenic dyslipidemia: the GEMS project. Angiology 59 (2008) 484-492
35. Mori Y., Itoh Y., Komiya H., et al. Association between postprandial remnant-like particle triglyceride (RLP-TG) levels and carotid intima-media thickness (IMT) in Japanese patients with type 2 diabetes: assessment by meal tolerance tests (MTT). Endocrine 28 (2005) 157-163
36. Shoji T., Hatsuda S., Tsuchikura S., et al. Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis. Atherosclerosis 202 (2009) 582-588
37. Riccioni G., Bazzano L.A., Bucciarelli T., et al. Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study. Expert Opin Pharmacother 9 (2008) 2403-2408
38. Rizzo M., Pernice V., Frasheri A., et al. Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease. Atherosclerosis 197 (2008) 237-241
39. Vaudo G., Marchesi S., Siepi D., et al. Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries. Metabolism 56 (2007) 541-546
40. Harrell Jr. F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
41. Altman D.G., and Royston P. What do we mean by validating a prognostic model?. Stat Med 19 (2000) 453-473
42. Mundry R., and Nunn C.L. Stepwise model fitting and statistical inference: turning noise into signal pollution. Am Nat 173 (2009) 119-123
43. Whittingham M.J., Stephens P.A., Bradbury R.B., et al. Why do we still use stepwise modelling in ecology and behaviour?. J Anim Ecol 75 (2006) 1182-1189
44. Steyerberg E.W., Eijkemans M.J., Harrell Jr. F.E., et al. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 19 (2000) 1059-1079
45. Austin P.C. Bootstrap model selection had similar performance for selecting authentic and noise variables compared to backward variable elimination: a simulation study. J Clin Epidemiol 61 (2008) 1009-1017.e1
46. Murabito J.M., Nam B.H., D'Agostino Sr. R.B., et al. Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med 140 (2004) 434-440
47. Imke C., Rodriguez B.L., Grove J.S., et al. Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart study. Arterioscler Thromb Vasc Biol 25 (2005) 1718-1722
48. Yu K.C., and Cooper A.D. Postprandial lipoproteins and atherosclerosis. Front Biosci 6 (2001) D332-D354
49. Austin M.A., King M.C., Vranizan K.M., et al. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82 (1990) 495-506
50. Steinberg D., Parthasarathy S., Carew T.E., et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320 (1989) 915-924
51. Robins S.J., Collins D., Wittes J.T., et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA 285 (2001) 1585-1591
52. Gardner D.S., Metcalf B.S., Hosking J., et al. Trends, associations and predictions of insulin resistance in prepubertal children (EarlyBird 29). Pediatr Diabetes 9 (2008) 214-220
53. Eisenmann J.C., Welk G.J., Wickel E.E., et al. Stability of variables associated with the metabolic syndrome from adolescence to adulthood: the Aerobics Center Longitudinal Study. Am J Hum Biol 16 (2004) 690-696
54. Laskarzewski P., Morrison J.A., deGroot I., et al. Lipid and lipoprotein tracking in children. Pediatr Res 13 (1979) 1082-1084